Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pancreatic cancer
MedTech
Novocure gets FDA nod for device targeting pancreatic cancer
The FDA gave the go-ahead to Novocure for its tumor-treating electric fields device that targets advanced pancreatic cancer alongside a drug combo.
Joseph Keenan
Feb 17, 2026 4:15am
Fierce Pharma
Astellas lifts forecast as Vyloy surge counters trial miss
Feb 5, 2026 11:00am
Immuneering touts 64% survival, fueling race with Revolution
Jan 8, 2026 5:17am
Bayer picks Kumquat for $1.3B KRAS collaboration
Aug 12, 2025 6:29am
Immuneering sees 94% survival at 6 months in pancreatic cancer
Jun 17, 2025 10:55am
OSE shares 65% OS rate behind cancer vaccine's phase 2 win
Jun 3, 2025 7:05am
